Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX – Get Free Report)’s share price fell 1.8% on Thursday . The stock traded as low as $0.71 and last traded at $0.72. 10,044 shares were traded during trading, a decline of 98% from the average session volume of 515,527 shares. The stock had previously closed at $0.73. Analyst Upgrades and […]
Quoin Pharmaceuticals (NASDAQ:QNRX – Get Free Report) and Titan Medical (NASDAQ:TMDIF – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, analyst recommendations, profitability, risk, valuation, institutional ownership and dividends. Analyst Recommendations This is a summary of […]
Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX – Get Free Report) saw a large growth in short interest in January. As of January 31st, there was short interest totalling 2,500 shares, a growth of 212.5% from the January 15th total of 800 shares. Based on an average daily trading volume, of 32,200 shares, the short-interest ratio is presently […]
Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX – Get Free Report) was the recipient of a significant decline in short interest in the month of November. As of November 30th, there was short interest totalling 1,000 shares, a decline of 85.7% from the November 15th total of 7,000 shares. Based on an average trading volume of 18,700 shares, […]
Company reported positive clinical data for QRX003 from first six evaluable subjects in ongoing open-label Netherton Syndrome study Positive benefits were.